Browse Data and Analysis

In January 2024, Nigeria became the second country in Africa to approve the commercial release of four biotech (TELA) maize varieties.

Kazakhstan has not announced any changes to its biotechnology policies. Major challenges like climate change, variable weather, monocropping wheat, and the reliance on Eurasian Economic Union (EAEU) member biotechnology regulations could be a future catalyst for Kazakhstan to develop its own biotechnology law.

In January 2024, Nigeria approved the commercial release of four TELA maize varieties, which have been genetically engineered for improved insect-resistance and drought-tolerance. In addition to South Africa, Nigeria has become the second country in...

In July 2023, President Tinubu declared an "immediate state of emergency on food insecurity" to address high food prices and lackluster agricultural production. Nigeria is considered by some in Africa to be a leader in agricultural biotechnology as it has researched, tested, evaluated, and commercialized several biotech products, including cowpea, a staple crop for smallholder farmers across West Africa.

Kazakhstan has not announced any changes to its biotechnology policies. Major challenges like climate change, variable weather, monocropping wheat, and the reliance on Eurasian Economic Union (EAEU) member biotechnology regulations could be a future catalyst for Kazakhstan to develop its own biotechnology law.

Nigeria has taken an increasingly active role in biotechnology research and development in Africa – spurred by the solid support of the Government of Nigeria (GON). In September 2022, Nigeria hosted regulators from Mozambique and Ethiopia to learn more about Nigeria’s biotechnology regulatory experience.

In the past year, there have been no major changes in Kazakhstan’s biotechnology policies, although the government may be making plans to regulate and commercialize agricultural biotechnologies. For the time being, Kazakhstan continues to rely on Eurasian Economic Union (EAEU) regulations for guidance on biotechnology issues.

Nigeria continues to deliver notable achievements in biotechnology research and development – spurred by strong support of the Government of Nigeria (GON).

In the past year, there have been no major changes in Kazakhstan’s biotechnology policy. Kazakhstan continues to rely on Eurasian Economic Union (EAEU) regulations for guidance on biotechnology issues.

In December 2020, the Government of Nigeria through the National Biosafety Management Agency (NBMA) authorized guidelines on gene editing.

Since the commercial release of Bt Cowpea in January 2019, Nigeria biotech regulatory authorities are forging ahead with other approvals.

In the past year, there have been no major changes in Kazakhstan’s biotechnology policy.